Key Takeaway
Semaglutide 2.4mg results timeline week by week. Learn when to expect weight loss milestones, appetite changes, and metabolic improvements at the full maintenance dose.
The semaglutide 2.4mg results timeline spans roughly 60 to 68 weeks from the first injection to peak weight loss. Most patients reach the 2.4mg maintenance dose around week 17 after titrating through four lower doses, and the most rapid weight loss occurs during weeks 17 through 40, with a gradual plateau forming between months 10 and 15.
The Full Timeline: Titration Through Maintenance
About the complete arc of semaglutide treatment helps set realistic expectations. Here is a detailed look at what happens at each phase:
Weeks 1 to 16: Dose Escalation (Before Reaching 2.4mg)
Before arriving at the maintenance dose, you spend approximately 16 weeks building tolerance through four dose steps: 0.25mg, 0.5mg, 1.0mg, and 1.7mg. During this period, you'll already notice progressive appetite changes and early weight loss. By the end of week 16, most patients have lost 8 to 12% of their starting body weight.
Nearly half of the total weight loss occurs before you even reach the full dose. The titration phase isn't wasted time. It's an active treatment period.
Weeks 17 to 28: Accelerated Loss at Full Dose
Once you reach 2.4mg, appetite suppression intensifies. Most patients describe the strongest reduction in hunger and food noise during weeks 17 to 28. This is the period of most rapid weight loss at the maintenance dose, with many patients losing 1 to 2 pounds per week.
By week 28 (roughly month 7), average cumulative weight loss reaches approximately 12 to 14% of starting body weight. Physical changes become very noticeable. Clothing sizes drop, facial features sharpen, and energy improves significantly.
Weeks 28 to 44: Steady Progress, Slower Pace
Weight loss continues during this phase but decelerates. Average weekly loss drops to 0.5 to 1 pound. This is normal and expected. As your body gets smaller, your metabolic rate decreases proportionally, which means the caloric deficit created by semaglutide narrows.
By week 44, cumulative weight loss typically reaches 13 to 16% of baseline weight. Patients in STEP 1[1] who were in the top quartile of responders had already exceeded 20% weight loss by this point.
Weeks 44 to 68: Plateau and Maintenance
Most patients reach their maximum weight loss between weeks 52 and 68. The average final weight loss in STEP 1 was 14.9% at 68 weeks. At this stage, weight stabilizes and the goal shifts from active loss to maintenance.
The plateau isn't a sign that the medication has stopped working. Semaglutide continues to suppress appetite and regulate metabolic processes. Without it, weight would begin to return. The plateau represents a new equilibrium between your reduced caloric intake and your body's adjusted metabolic needs.
Milestone Expectations by Week
| Week | Dose | Average Weight Loss | What You May Notice |
|---|---|---|---|
| 4 | 0.25mg | 1 to 3% | Mild appetite reduction, possible nausea |
| 8 | 0.5mg | 3 to 5% | Smaller portions feel satisfying, early scale changes |
| 12 | 1.0mg | 5 to 8% | Food cravings diminish, clothes fit differently |
| 16 | 1.7mg | 8 to 12% | Visible body composition changes, improved energy |
| 28 | 2.4mg | 12 to 14% | Significant appearance change, metabolic markers improving |
| 44 | 2.4mg | 13 to 16% | Rate of loss slows, close to plateau |
| 68 | 2.4mg | 14 to 17% | Weight plateau, maintenance phase begins |
Non-Scale Results You Will Notice
Weight on the scale is just one measure. At 2.4mg, patients commonly report improvements across many dimensions: For a complete cost breakdown, see our cheapest semaglutide options.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →View data table
| Category | Mean Body Weight Loss (%) | Detail |
|---|---|---|
| Tirzepatide | 22 | ~22% body weight at 72 wks |
| Semaglutide | 15 | ~15% body weight at 68 wks |
| Liraglutide | 8 | ~8% body weight at 56 wks |
| Retatrutide | 24 | ~24% in Phase 2 trial |
- Blood pressure: Average systolic reduction of 4 to 5 mmHg, often within 3 months of reaching maintenance dose
- Blood sugar: HbA1c improvements of 0.5 to 1.5 points for patients with prediabetes or diabetes, often measurable by month 3
- Cholesterol: Triglycerides decrease 12 to 18% on average. LDL and total cholesterol also improve modestly
- Inflammation: CRP drops by up to 37%, which may reduce joint pain, cardiovascular risk, and fatigue
- Sleep: Patients with obstructive sleep apnea report fewer apneic events and better sleep quality as neck and airway fat decreases
- Joint pain: Reduced mechanical loading on knees and hips provides measurable pain relief for many patients with osteoarthritis
What If Your Results Are Slower Than Average
Individual variation is significant. If your weight loss at 2.4mg is slower than the averages described above, consider these factors:
- Type 2 diabetes: Patients with T2D consistently lose less weight on semaglutide than non-diabetic patients, averaging about 10% in the STEP 2 trial[2]
- Medications: Insulin, sulfonylureas, beta-blockers, and certain antidepressants can counteract weight loss
- Dietary patterns: Semaglutide reduces appetite but doesn't eliminate the ability to overeat. Liquid calories, ultra-processed snacks, and mindless eating can blunt results
- Caloric floor: If you're already eating very little, there may not be much more appetite to suppress. Focus on exercise and body composition rather than the scale
- Genetics: GLP-1 receptor polymorphisms and individual metabolic profiles create a wide response range
Being a slower responder doesn't mean the medication isn't working. A 7 to 10% weight loss is still clinically significant and produces measurable health improvements. semaglutide weight loss plateau
Medical References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. [PubMed | ClinicalTrials.gov | DOI]
- Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). Lancet. 2021;397(10278):971-984. [PubMed | ClinicalTrials.gov | DOI]
- Garvey WT, Batterham RL, Bhatt DL, et al. Two-year effects of semaglutide in adults with overweight or obesity (STEP 5). Nat Med. 2022;28(10):2083-2091. [PubMed | ClinicalTrials.gov | DOI]
Frequently Asked Questions
- When will I see the most weight loss on semaglutide 2.4mg?
- The most rapid weight loss after reaching 2.4mg typically occurs during weeks 17 through 28. This is when the full dose is new to your system and appetite suppression is at its strongest. After that, loss continues but slows progressively.
- How much total weight can I expect to lose?
- The average in clinical trials was 14.9% of body weight[1] at 68 weeks. For a 250-pound person, that's roughly 37 pounds. About one-third of patients lose 20% or more.
- What happens after 68 weeks?
- The STEP 5 trial[3] followed patients for 2 years and showed that weight loss was maintained as long as semaglutide was continued. Average weight loss at 104 weeks was approximately 15.2%.
- Will I regain weight if I stop semaglutide 2.4mg?
- The STEP 1 extension study showed that participants who stopped semaglutide after 68 weeks regained approximately two-thirds of their lost weight within one year. This supports continued use for weight maintenance.
- Is the timeline different for men vs. women?
- Clinical trial data doesn't show a significant gender-based difference in overall percentage weight loss on semaglutide. Men may lose slightly more absolute pounds due to higher starting weights, but the percentage loss and timeline are similar.
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →